Literature DB >> 25697685

Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis.

Guoyu Niu1, Zheng Pang2, Chun Guan3, Jun Qi4, Dexin Li5.   

Abstract

In the present study, we developed a tetravalent protein by connecting the receptor-binding envelope domain III (EDIII) of the four dengue virus serotypes in the order of D1-D3-D4-D2. Using a baculovirus expression system, the protein was secreted into the supernatant of infected sf9 cells in a stable form with preserved native conformation. Using immobilized affinity chromatography, the recombinant EDIII (rEDIII) protein was purified with a yield of 300μg per 10(6) cells. The purity and reactivity of the protein were determined via SDS-PAGE and Western blot respectively. A MAC-ELISA method based on the secreted rEDIII protein was subsequently established and evaluated using a panel of pre-characterized dengue IgM-positive and -negative human sera. We obtained a specificity of 100% and sensitivity of 93% using this method. Our data collectively suggest that the secreted tetravalent rEDIII protein has potential utility in the diagnosis of dengue virus infections.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dengue virus; Diagnosis; Secretion; Tetravalent

Mesh:

Substances:

Year:  2015        PMID: 25697685     DOI: 10.1016/j.virusres.2015.02.008

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

Review 1.  Recent Developments in Recombinant Protein-Based Dengue Vaccines.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Immunol       Date:  2018-08-23       Impact factor: 7.561

2.  The Dengue ED3 Dot Assay, a Novel Serological Test for the Detection of Denguevirus Type-Specific Antibodies and Its Application in a Retrospective Seroprevalence Study.

Authors:  Heidi Auerswald; Leonard Klepsch; Sebastian Schreiber; Janne Hülsemann; Kati Franzke; Simone Kann; Bunthin Y; Veasna Duong; Philippe Buchy; Michael Schreiber
Journal:  Viruses       Date:  2019-03-27       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.